Promoting Patient Safety
& Better Clinical Outcome
Hospitech Respiration provides an innovative therapeutic approach to mechanically ventilated patients.
Airway Management Solutions
Founded in 2006, Hospitech Respiration Ltd is committed to the development and commercialization of innovative medical devices, aimed at enhancing the quality of care, promoting patient safety and reducing complications in mechanically ventilated patients.
Israeli startup protects intubated COVID-19 patients from complications
14.04 .2020 I Rossella Tercatin
Device preventing ventilator complications offered to Israeli hospitals during COVID-19 pademic
1.04.2020 | Sophie Porter
The device from Israel that saves patients live in China
10.3.2020 | Ran Raznic
AnapnoGuard Helps Prevent Ventilator Complications
April 1st, 2020 | CICI ZHOU
Israeli Medical Start-Up, has stepped forward to help the Corona crisis
29.3.2020 | IFI
How to reduce mechanical ventilation complications?
An Israeli device designed to help
26.03.2020 I Gali Winreb
Channel N12 NEXT
The AnapnoGuard solution provides the clinical staff with the tools for better management of mechanically ventilated patients by taking care of two critical aspects:
Automated Airway cuff pressure control and effective evacuation of subglottic secretions.
Automated ET Tube Cuff Pressure Control
Cuff pressure management, provided by the AnapnoGuard solution, ensures tracheal sealing at the minimum cuff pressure. Appropriate sealing of the trachea, allows for positive pressure ventilation while minimizing aspiration of subglottic secretions and diminishing the likelihood of tracheal tissue injuries, such as mucosal edema, ulceration, fistula, granulomas and injuries to the vocal cords.
The AnapnoGuard solution monitors air leakage from the lungs around the airway cuff, based on continuous measurement of CO2 levels in the subglottic space, above the cuff. High levels of CO2 above the cuff indicate leakage. Therefore, if the system detects a rise in CO2 level above the cuff, it increases the cuff pressure to the minimal pressure needed to ensure tracheal sealing. If no leak is detected, the system decreases the cuff pressure over time, as long as sealing is maintained. The cuff pressure is adjusted within a pressure range that has been predetermined by the clinician.
If the AnapnoGuard AG100s control unit is not available, easy monitoring and adjustment of the ET Tube cuff pressure can be achieved with the manual digital manometer, the AG Cuffill.
Effective Evacuation of Subglottic Secretions
The AnapnoGuard solution is designed to ensure effective sealing of the trachea at minimal cuff pressure, while effectively evacuating the subglottic secretions. These functions reduce pulmonary aspiration of subglottic secretions which are known to be a significant contributor to the development of Ventilator-Associated Pneumonia (VAP) and Ventilator-Associated Respiratory Infection (VARI).
The AnapnoGuard ET Tube, comprising of three unique lumens, in conjunction with the AnapnoGuard AG100s control unit, allows simultaneous subglottic rinsing or venting and evacuation of subglottic secretions.
In clinical settings, where the AnapnoGuard AG100s control unit is not available, effective rinsing and suction of the subglottic secretions can be achieved manually with the single-use AG MASS device.
For manual cuff pressure measurement and adjustment